Sur cette page
NTRA Natera, Inc. - Common Stock
NASDAQ · Biotechnology · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 7, 2026
$410,35
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$160,59Bas 52 semaines
$427,47Haut 52 semaines
Capitalisation Boursière (MRQ)
$58.93B
P/E (TTM)
-304.0
BPA (TTM)
$-1.35
Revenu (TTM)
$2.71B
vos badges
Fourchette 52 semaines
$161–$427
Note des analystes
BUY
Objectif de cours
$353
P/E
-304.0
ROE
-12.5%
Marge nette
-7.1%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
NTRA Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$410.35
Capitalisation Boursière (MRQ)
$58.93B
P/E (TTM)
-304.0
BPA (TTM)
$-1.35
Revenu (TTM)
$2.71B
ROE (TTM)
-12.5%
Dette/Capitaux propres (MRQ)
0.0
Fourchette 52 semaines
$161–$427
NTRA Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
À propos de Natera, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
History
Natera (previously Gene Security Network) was founded by Matthew Rabinowitz and Jonathan Sheena in 2004. Natera launched its first product, the Spectrum preimplantation genetic test, in 2009.
In 2010, the company introduced the Anora miscarriage (POC) test. Natera's advanced carrier screening test, Horizon, launched in 2012. The following year, 2013, Natera launched the Panorama non-invasive prenatal test (NIPT).
In July 2015, Natera conducted an initial public offering of common stock at a price of $18.00 per share. The shares trade on the Nasdaq Global Select Market under the symbol "NTRA."
In 2017, Natera launched the Vistara single-gene NIPT. That same year, Natera introduced the Signatera molecular residual disease (MRD) test for research use only. The Signatera CLIA test was introduced for clinical use in 2019.
In 2018 Natera paid a $11 million fine to the department over allegations of improper billing and sales of Panorama to federal Healthcare services between the years of 2013 to 2016.
Natera launched the Prospera dd-cfDNA transplant assessment test in 2019, and the Renasight kidney gene panel and the Empower hereditary cancer test in 2020.
As of May 2021, Natera has performed over 3 million cell-free DNA tests. Natera's technology has also been written about in over 200 peer-reviewed journals and publications, including Nature, Science Magazine, and the Journal of Clinical Oncology.
Products and services
Women's health
The Panorama NIPT is the only single-nucleotide polymorphism (SNP)-based NIPT. The test analyzes fetal DNA found in the mother's blood to reveal a baby's risk for genetic disorders such as Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18) as early as nine weeks. Panorama also tests for unique microdeletions and is the only test that can detect zygosity and fetal sex in twins.
Natera also offers Horizon, a carrier-screening test that uses next-generation sequencing to provide carrier status for up to 274 genetic conditions. Additionally, Natera offers the Anora products of conception (POC) miscarriage test, the Spectrum preimplantation genetic screening and diagnosis test, and the Vistara single-gene prenatal screening test. In 2020, Natera launched Empower, a hereditary cancer test that screens for up to 53 genes associated with increased risk for common hereditary cancers.
Oncology
Signatera is the first circulating tumor DNA (ctDNA) assay built for molecular residual disease (MRD) detection and cancer recurrence monitoring. In 2020, Signatera received the CE Mark, as well as final Medicare coverage in stage II-III colorectal cancer and draft coverage in immunotherapy response monitoring. Signatera has been clinically validated to detect colorectal cancer recurrence up to 16.5 months in advance of radiologic imaging and early-stage breast cancer up to two years earlier than imaging.
Organ health
The Prospera test is the first assay with high sensitivity to both T-cell-mediated and antibody-mediated rejection. In December 2019, the test received final Medicare coverage. In 2020, Natera launched Renasight, a test to determine if there is a genetic cause for an individual's kidney disease and if there may be other at-risk relatives.
Constellation
Natera offers a cloud-based bioinformatics platform called Constellation, allowing laboratories to access and use Natera's technology in their own facilities. Constellation is currently only available outside of the United States.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
secteurHealthcare
industrieBiotechnology
employés6 135
paysUS
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$2.31B2016-12-31 → 2025-12-31
BPA$-1.522016-12-31 → 2025-12-31
Flux de trésorerie libre$109M2016-12-31 → 2025-12-31
Marge nette-7.1%2016-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | NTRA | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -304.0moyenne 5 ans ≈-59.2 | ≈-59.2 | · | · | |
| P/S (TTM) | 21.8moyenne 5 ans ≈10.6 | ≈10.6 | 7.3 | Surévalué | |
| P/B (MRQ) | 32.4moyenne 5 ans ≈13.2 | ≈13.2 | 6.2 | Surévalué | |
| Cours / FCF (TTM) | 699.9moyenne 5 ans ≈107.5 | ≈107.5 | · | · | |
| Cours / Flux de trésorerie (TTM) | 258.2moyenne 5 ans ≈47.2 | ≈47.2 | 18.3 | Surévalué | |
| Cours / Actif net tangible (MRQ) | 40.3moyenne 5 ans ≈14.8 | ≈14.8 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | NTRA | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge d'exploitation (TTM) | -10.7%moyenne 5 ans ≈-41.7% | ≈-41.7% | 24.0% | Faible | |
| Marge EBITDA (TTM) | -8.8%moyenne 5 ans ≈-39.8% | ≈-39.8% | 17.9% | Faible | |
| Marge avant impôts (TTM) | -9.3%moyenne 5 ans ≈-41.0% | ≈-41.0% | 13.8% | Faible | |
| Marge nette (TTM) | -7.1%moyenne 5 ans ≈-40.5% | ≈-40.5% | 12.7% | Faible | |
| ROA (TTM) | -8.7%moyenne 5 ans ≈-27.7% | ≈-27.7% | 11.5% | Faible | |
| ROE (TTM) | -12.5%moyenne 5 ans ≈-51.6% | ≈-51.6% | 18.7% | Faible | |
| ROIC | -13.4%moyenne 5 ans ≈-43.9% | ≈-43.9% | 17.3% | Faible |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | NTRA | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Dette / Capitaux propres (MRQ) | 0.0moyenne 5 ans ≈0.1 | ≈0.1 | 0.1 | Faible endettement | |
| Ratio de liquidité (MRQ) | 3.0moyenne 5 ans ≈4.1 | ≈4.1 | 3.2 | Faible liquidité | |
| Quick Ratio (Ratio de liquidité réduite) | 0.7moyenne 5 ans ≈2.3 | ≈2.3 | 2.5 | Faible liquidité | |
| Interest Coverage (Ratio de couverture des intérêts) | -76.2moyenne 5 ans ≈-49.3 | ≈-49.3 | 8.1 | Faible liquidité |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | NTRA | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | 35.9%moyenne 5 ans ≈43.1% | ≈43.1% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 41.1%moyenne 5 ans ≈40.3% | ≈40.3% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 42.6% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | NTRA | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 1.1moyenne 5 ans ≈0.8 | ≈0.8 | 0.5 | Premier rang | |
| Receivables Turnover (Rotation des créances) | 7.6moyenne 5 ans ≈5.6 | ≈5.6 | 6.4 | Premier rang | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$375.9K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
17.2%
Prochain rapport
Nov 04, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 5, 2026 | $-0.47 | $-0.50 | 6.7% |
| 31 mars 2026 | Mai 7, 2026 | $-0.60 | $-0.55 | -9.7% |
| 31 décembre 2025 | $0.36 | $-0.52 | 169.1% | |
| 30 septembre 2025 | $-0.64 | $-0.38 | -68.2% | |
| 30 juin 2025 | $-0.74 | $-0.63 | -17.8% | |
| 31 mars 2025 | $-0.50 | $-0.65 | 23.1% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | $159M | |
| Cost of Revenue | · | · | · | · | · | · | · | $158M | $136M | $134M | $113M | $78M | |
| R&D Expense | $624M | $404M | $321M | $316M | $264M | $100M | $51M | $51M | $50M | $42M | $28M | $17M | |
| SG&A Expense | $1.18B | $841M | $618M | $589M | $511M | $304M | $206M | $155M | $155M | $136M | $110M | $63M | |
| Operating Expenses | $2.62B | $1.92B | $1.53B | $1.36B | $1.09B | $607M | $419M | $372M | $345M | $314M | $250M | $159M | |
| Operating Income | $-310M | $-222M | $-446M | $-541M | $-468M | $-216M | $-116M | $-115M | $-135M | $-101M | $-60M | $665.0K | |
| Interest Expense | $4M | $11M | $13M | $9M | $8M | $15M | $11M | $10M | $4M | $533.0K | $4M | $4M | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $-8M | $-2M | |
| Pretax Income | $-268M | $-190M | $-435M | $-547M | $-471M | $-230M | $-123M | $-128M | $-137M | $-100M | $-70M | $-5M | |
| Income Tax | $-60M | $695.0K | $271.0K | $978.0K | $618.0K | $98.0K | $2M | $321.0K | $454.0K | $142.0K | · | $15.0K | |
| Net Income | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | $-5M | |
| EPS (Basic) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.58 | $-1.95 | $-2.68 | · | |
| EPS (Diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · | |
| Shares (Basic) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,312,000 | 51,576,000 | 26,204,000 | · | |
| Shares (Diluted) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,604,000 | 51,576,000 | 26,204,000 | · | |
| EBITDA | $-268M | $-191M | $-422M | $-524M | $-457M | $-208M | $-109M | $-107M | $-127M | $-90M | $-54M | · |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $466M | $84M | $49M | $62M | $46M | $13M | $15M | $29M | $87M | |
| Short-term Investments | · | $23M | $237M | $432M | $830M | $689M | $379M | $107M | $106M | $131M | $202M | · | |
| Receivables | $297M | $314M | $278M | $244M | $122M | $79M | $53M | $62M | $44M | $13M | $6M | $6M | |
| Inventory | $68M | $45M | $41M | $35M | $27M | $20M | $12M | $14M | $9M | $6M | $8M | $12M | |
| Prepaid Expense | $56M | $49M | $61M | $34M | $30M | $27M | $16M | $6M | $9M | $7M | $5M | $1M | |
| Current Assets | $1.50B | $1.38B | $1.26B | $1.21B | $1.09B | $863M | $523M | $241M | $181M | $174M | $251M | $106M | |
| PP&E (Net) | $241M | $162M | $111M | $92M | $66M | $33M | $23M | $24M | $30M | $32M | $13M | $15M | |
| PP&E (Gross) | $352M | $240M | $168M | $128M | $85M | $83M | $65M | $59M | $57M | $52M | $26M | $24M | |
| Accum. Depreciation | $111M | $78M | $56M | $36M | $19M | $50M | $42M | $34M | $27M | $19M | $14M | $10M | |
| Goodwill | $141M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $374M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $37M | $26M | $15M | $18M | $19M | $15M | $12M | $3M | $4M | $4M | $1M | $2M | |
| Total Assets | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Accounts Payable | $33M | $35M | $15M | $31M | $27M | $8M | $9M | $15M | $9M | $11M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | · | $60M | $49M | $32M | $33M | $20M | $19M | $10M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Current Liabilities | $441M | $344M | $307M | $310M | $219M | $199M | $180M | $114M | $106M | $96M | $80M | $30M | |
| Capital Leases | $118M | $97M | $67M | $77M | $61M | $21M | $26M | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $8M | · | · | $1M | $320.0K | $310.0K | · | $1M | · | · | · | |
| Total Liabilities | $686M | $465M | $676M | $689M | $583M | $446M | $304M | $236M | $189M | $104M | $80M | $54M | |
| Long-term Debt | · | · | $283M | $282M | $280M | · | · | · | · | · | · | · | |
| Total Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Common Stock | $14.0K | $12.0K | $11.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $1.0K | |
| Retained Earnings | $-2.78B | $-2.57B | $-2.38B | $-1.94B | $-1.39B | $-929M | $-699M | $-575M | $-446M | $-346M | $-250M | $-180M | |
| AOCI | $-258.0K | $-344.0K | $-3M | $-16M | $-2M | $4M | $919.0K | $-552.0K | $-766.0K | $-725.0K | $-1M | · | |
| Stockholders' Equity | $1.71B | $1.20B | $765M | $706M | $653M | $486M | $279M | $32M | $25M | $144M | $226M | $-171M | |
| Liabilities + Equity | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Shares Outstanding | 139,693,000 | 132,646,000 | 119,581,000 | 111,255,000 | 95,140,000 | 86,223,000 | 78,005,000 | 62,083,000 | 54,040,000 | 52,665,000 | 50,346,000 | 6,879,000 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $31M | $24M | $17M | $11M | $9M | $8M | $8M | $7M | $6M | $6M | $5M | |
| Stock-based Comp | $354M | $274M | $192M | $152M | $115M | $50M | $29M | $14M | $11M | $11M | $7M | $5M | |
| Amort. of Intangibles | $4M | $1M | $0 | · | · | · | $1M | $1M | $1M | $600.0K | $200.0K | $0 | |
| Restructuring | · | · | · | · | $400.0K | $400.0K | · | · | · | · | · | · | |
| Other Non-cash | $27M | $21M | $-28M | $-53M | $10M | $-12M | $25M | $36M | $21M | $5M | $20M | · | |
| Operating Cash Flow | $215M | $136M | $-247M | $-432M | $-335M | $-183M | $-63M | $-71M | $-98M | $-74M | $-38M | $10M | |
| CapEx | $106M | $66M | $39M | $48M | $41M | $20M | $5M | $4M | $10M | $23M | $8M | $10M | |
| Investing Cash Flow | $-132M | $138M | $168M | $330M | $-205M | $-331M | $-266M | $-5M | $14M | $47M | $-211M | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Financing Cash Flow | $47M | $30M | $254M | $483M | $576M | $501M | $341M | $114M | $80M | $13M | $190M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-3M | $-14M | $-58M | · | |
| Taxes Paid | $499.0K | $1M | $295.0K | $549.0K | $283.0K | $67.0K | $2M | $332.0K | $177.0K | · | · | · | |
| Free Cash Flow | $109M | $69M | $-286M | $-479M | $-376M | $-202M | $-68M | $-74M | $-107M | $-97M | $-46M | · | |
| Levered FCF | $106M | $59M | $-299M | $-489M | $-385M | $-217M | $-79M | $-85M | $-111M | $-98M | · | · |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% | -55.3% | -38.5% | -44.5% | -63.5% | -44.5% | -31.4% | · | |
| Net Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | · | |
| Pretax Margin | -11.6% | -11.2% | -40.1% | -66.7% | -75.3% | -58.7% | -40.6% | -49.6% | -64.4% | -44.0% | · | · | |
| EBITDA Margin | -11.6% | -11.3% | -39.0% | -63.9% | -73.0% | -53.1% | -35.9% | -41.6% | -60.2% | -41.6% | -28.5% | · | |
| ROA | -10.3% | -12.3% | -30.7% | -41.6% | -43.5% | -30.3% | -29.3% | -53.1% | -70.0% | -40.2% | -36.1% | · | |
| ROE | -14.1% | -18.4% | -56.1% | -102.6% | -66.8% | -45.0% | -68.7% | -288.9% | -204.7% | -57.5% | -1046.5% | · | |
| ROIC | -13.4% | -17.5% | -52.8% | -69.0% | -66.6% | -40.4% | -35.9% | -139.6% | -338.4% | -61.9% | · | · |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 | 4.3 | 2.9 | 2.1 | 1.4 | 1.8 | 3.1 | · | |
| Quick Ratio | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 | 4.1 | 2.7 | 1.9 | 1.2 | 1.7 | 2.9 | · | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 1.6 | -4.8 | 0.5 | 0.2 | · | |
| Interest Coverage | -76.2 | -20.8 | -35.3 | -58.1 | -56.4 | -14.3 | -10.9 | -10.9 | -31.8 | -181.0 | -17.1 | · |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.1 | 0.8 | 0.6 | 0.6 | 0.5 | 0.7 | 1.1 | 1.1 | 0.9 | 1.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 14.0 | 17.6 | 18.7 | 11.5 | · | |
| Receivables Turnover | 7.6 | 5.7 | 4.1 | 4.5 | 6.2 | 5.9 | 5.2 | 4.8 | 19.5 | 22.5 | 32.3 | · |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.26 | $9.01 | $6.40 | $6.34 | $6.87 | $5.64 | $3.57 | $0.52 | $-0.19 | $2.02 | $3.67 | · | |
| Revenue / Share | $16.87 | $13.61 | $9.41 | $8.33 | $6.91 | · | $4.35 | $4.45 | $3.94 | · | · | · | |
| Cash Flow / Share | $1.57 | $1.09 | $-2.15 | $-4.38 | $-3.70 | · | $-0.91 | $-1.22 | $-1.81 | · | · | · | |
| Cash / Share | · | · | · | $4.19 | $0.89 | $0.56 | $0.79 | $0.75 | $0.23 | $0.29 | $0.57 | · | |
| EPS (TTM) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 35.9% | 56.8% | 32.0% | 31.1% | 60.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 41.1% | 39.5% | 40.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 42.6% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | · | |
| Net Income TTM | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | · | |
| Market Cap | $32.00B | $21.00B | $7.49B | $4.47B | $8.89B | $8.58B | $2.63B | $867M | $486M | $617M | $544M | · | |
| Enterprise Value | · | · | · | $3.65B | $8.02B | $7.89B | $2.24B | $763M | $417M | $520M | $355M | · | |
| P/E | -150.7 | -103.5 | -16.6 | -7.2 | -17.9 | -35.0 | -18.8 | -6.3 | -3.5 | -6.0 | -4.0 | · | |
| P/S | 13.9 | 12.4 | 6.9 | 5.4 | 14.2 | 21.9 | 8.7 | 3.4 | 2.3 | 2.9 | 2.9 | · | |
| P/B | 18.7 | 17.6 | 9.8 | 6.3 | 13.6 | 17.6 | 9.4 | 26.9 | -46.8 | 5.8 | 2.9 | · | |
| P / Tangible Book | 26.7 | 17.7 | 9.8 | 6.3 | 13.6 | 17.6 | · | · | · | · | · | · | |
| P / Cash Flow | 148.6 | 154.8 | -30.3 | -10.4 | -26.5 | -47.0 | -41.4 | -12.3 | -5.0 | -8.3 | -14.4 | · | |
| P / FCF | 293.3 | 303.3 | -26.2 | -9.3 | -23.6 | -42.5 | -38.4 | -11.6 | -4.6 | -6.4 | -11.9 | · | |
| EV / EBITDA | · | · | · | -7.0 | -17.6 | -38.0 | -20.6 | -7.1 | -3.3 | -5.8 | -6.5 | · | |
| EV / FCF | · | · | · | -7.6 | -21.3 | -39.1 | -32.7 | -10.2 | -3.9 | -5.4 | -7.8 | · | |
| EV / Revenue | · | · | · | 4.5 | 12.8 | 20.2 | 7.4 | 3.0 | 2.0 | 2.4 | 1.9 | · | |
| Earnings Yield | -0.66% | -0.97% | -6.0% | -13.9% | -5.6% | -2.9% | -5.3% | -15.9% | -28.8% | -16.7% | -24.8% | · |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753M | $697M | $666M | $592M | $547M | $502M | $476M | $440M | $413M | $368M | $311M | $268M | $261M | $242M | $217M | $211M | |
| R&D Expense | $228M | $211M | $175M | $173M | $146M | $129M | $129M | $97M | $89M | $89M | $83M | $77M | $78M | $82M | $88M | $66M | |
| SG&A Expense | $327M | $328M | $291M | $309M | $311M | $267M | $235M | $214M | $198M | $194M | $161M | $155M | $153M | $150M | $144M | $148M | |
| Operating Expenses | $829M | $790M | $688M | $690M | $657M | $581M | $541M | $479M | $457M | $442M | $396M | $379M | $374M | $380M | $359M | $330M | |
| Operating Income | $-76M | $-94M | $-23M | $-98M | $-110M | $-79M | $-65M | $-39M | $-44M | $-74M | $-85M | $-111M | $-112M | $-138M | $-142M | $-119M | |
| Interest Expense | · | · | $990.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Other Non-op | $9M | $10M | · | · | $11M | $13M | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-67M | $-85M | $-13M | $-87M | $-101M | $-67M | $-55M | $-31M | $-37M | $-67M | $-78M | $-109M | $-111M | $-137M | $-142M | $-121M | |
| Income Tax | $-261.0K | $283.0K | $-61M | $207.0K | $275.0K | $173.0K | $-1M | $730.0K | $892.0K | $428.0K | $191.0K | $202.0K | $-282.0K | $160.0K | $421.0K | $185.0K | |
| Net Income | $-67M | $-85M | $47M | $-88M | $-101M | $-67M | $-54M | $-32M | $-37M | $-68M | $-78M | $-109M | $-111M | $-137M | $-143M | $-121M | |
| EPS (Basic) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| EPS (Diluted) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| Shares (Basic) | 143,279,000 | 141,502,000 | · | 137,187,000 | 136,388,000 | 134,750,000 | · | 123,775,000 | 122,853,000 | 120,814,000 | · | 115,171,000 | 113,690,000 | 111,767,000 | · | 97,052,000 | |
| Shares (Diluted) | 143,279,000 | 141,502,000 | · | 137,187,000 | 136,388,000 | 134,750,000 | · | 123,775,000 | 122,853,000 | 120,814,000 | · | 115,171,000 | 113,690,000 | 111,767,000 | · | 97,052,000 | |
| EBITDA | $-76M | $-79M | · | $-98M | $-110M | $-70M | · | $-39M | $-44M | $-67M | · | $-111M | $-112M | $-133M | · | $-119M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $57M | |
| Short-term Investments | · | · | · | $1M | $16M | $18M | $23M | $29M | $90M | $69M | · | $268M | $355M | $409M | · | $464M | |
| Receivables | $422M | $418M | $297M | $286M | $309M | $318M | $314M | $307M | $336M | $289M | · | $255M | $260M | $247M | · | $236M | |
| Inventory | $80M | $71M | $68M | $65M | $54M | $50M | $45M | $49M | $41M | $43M | · | $42M | $43M | $41M | · | $40M | |
| Prepaid Expense | $65M | $76M | $56M | $54M | $52M | $56M | $49M | $45M | $38M | $47M | · | $33M | $27M | $30M | · | $32M | |
| Current Assets | $1.66B | $1.65B | $1.50B | $1.45B | $1.43B | $1.42B | $1.38B | $1.32B | $1.30B | $1.26B | · | $1.27B | $1.07B | $1.13B | · | $830M | |
| PP&E (Net) | $318M | $269M | $241M | $206M | $189M | $180M | $162M | $142M | $133M | $126M | · | $105M | $103M | $101M | · | $87M | |
| PP&E (Gross) | $451M | $390M | $352M | $307M | $281M | $267M | $240M | $213M | $198M | $185M | · | $155M | $148M | $141M | · | $119M | |
| Accum. Depreciation | $133M | $120M | $111M | $101M | $92M | $87M | $78M | $71M | $64M | $59M | · | $51M | $45M | $41M | · | $31M | |
| Goodwill | $141M | $141M | $141M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $360M | $367M | $374M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $50M | $51M | $37M | $71M | $41M | $41M | $26M | $38M | $29M | $26M | · | $16M | $18M | $19M | · | $18M | |
| Total Assets | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Accounts Payable | $75M | $62M | $33M | $46M | $37M | $39M | $35M | $28M | $33M | $26M | · | $21M | $21M | $36M | · | $34M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Current Liabilities | $553M | $558M | $441M | $442M | $385M | $366M | $344M | $301M | $315M | $306M | · | $290M | $277M | $291M | · | $267M | |
| Capital Leases | $143M | $145M | $118M | $104M | $103M | $103M | $97M | $99M | $61M | $64M | · | $68M | $71M | $74M | · | $78M | |
| Other Non-current Liabilities | $25M | $16M | $12M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $836M | $840M | $686M | $569M | $511M | $493M | $465M | $712M | $680M | $674M | · | $662M | $652M | $668M | · | $647M | |
| Total Debt | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $11.0K | $11.0K | $11.0K | · | $10.0K | |
| Retained Earnings | $-2.93B | $-2.86B | $-2.78B | $-2.82B | $-2.74B | $-2.63B | $-2.57B | $-2.51B | $-2.48B | $-2.45B | · | $-2.30B | $-2.19B | $-2.08B | · | $-1.80B | |
| AOCI | $-108.0K | $-202.0K | $-258.0K | $-187.0K | $-287.0K | $-197.0K | $-344.0K | $-765.0K | $-1M | $-2M | $-3M | $-5M | $-9M | $-12M | $-16M | $-20M | |
| Stockholders' Equity | $1.82B | $1.77B | $1.71B | $1.25B | $1.25B | $1.24B | $1.20B | $879M | $837M | $794M | $765M | $785M | $596M | $651M | $706M | $362M | |
| Liabilities + Equity | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Shares Outstanding | 143,612,000 | 142,734,000 | 139,693,000 | 137,533,000 | 136,757,000 | 135,932,000 | 132,646,000 | 124,137,000 | 123,365,000 | 122,234,000 | · | 118,990,000 | 114,051,000 | 113,359,000 | · | 97,300,000 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $15M | $12M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $4M | $5M | |
| Stock-based Comp | $103M | $95M | $93M | $91M | $93M | $78M | $72M | $71M | $67M | $64M | $49M | $57M | $44M | $40M | $36M | $40M | |
| Amort. of Intangibles | $6M | $7M | · | · | $0 | $300.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $16M | · | · | · | $24M | · | · | · | $23M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $55M | $40M | $74M | $59M | $38M | $44M | $53M | $52M | $4M | $27M | $-58M | $-30M | $-79M | $-81M | $-81M | $-102M | |
| CapEx | $63M | $22M | $36M | $22M | $26M | $22M | $18M | $16M | $12M | $20M | $10M | $9M | $9M | $11M | $12M | $12M | |
| Investing Cash Flow | $-63M | $-32M | $-72M | $-20M | $-24M | $-17M | $-11M | $43M | $-32M | $138M | $24M | $82M | $47M | $16M | $22M | $67M | |
| Financing Cash Flow | $12M | $4M | $32M | $2M | $13M | $544.0K | $11M | $2M | $11M | $6M | $7M | $236M | $9M | $2M | $468M | $1M | |
| Net Change in Cash | $4M | $12M | · | · | $26M | $28M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $18M | · | · | · | $23M | · | · | · | $7M | · | · | · | $-92M | · | · | |
| Levered FCF | · | · | · | · | · | $22M | · | · | · | $4M | · | · | · | $-96M | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10.1% | -13.4% | · | -16.5% | -20.2% | -15.8% | · | -8.9% | -10.6% | -20.2% | · | -41.4% | -43.0% | -57.2% | · | -56.5% | |
| Net Margin | -8.9% | -12.2% | · | -14.8% | -18.5% | -13.3% | · | -7.2% | -9.1% | -18.4% | · | -40.6% | -42.4% | -56.6% | · | -57.7% | |
| Pretax Margin | -8.9% | -12.2% | · | -14.8% | -18.4% | -13.3% | · | -7.0% | -8.8% | -18.3% | · | -40.6% | -42.5% | -56.6% | · | -57.6% | |
| EBITDA Margin | -10.1% | -11.3% | · | -16.5% | -20.2% | -13.9% | · | -8.9% | -10.6% | -18.3% | · | -41.4% | -43.0% | -55.1% | · | -56.5% | |
| ROA | -3.0% | -3.9% | · | -5.1% | -6.2% | -4.2% | · | -2.1% | -2.7% | -4.9% | · | -8.9% | -9.6% | -11.1% | · | -10.5% | |
| ROE | -4.4% | -5.7% | · | -8.2% | -9.7% | -6.6% | · | -3.8% | -5.2% | -9.4% | · | -19.0% | -21.3% | -23.0% | · | -21.7% | |
| ROIC | -4.0% | -5.1% | · | -7.3% | -8.3% | -6.0% | · | -4.2% | -4.9% | -8.6% | · | -12.8% | -16.6% | -18.9% | · | -29.0% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.0 | · | 3.3 | 3.7 | 3.9 | · | 4.4 | 4.1 | 4.1 | · | 4.4 | 3.8 | 3.9 | · | 3.1 | |
| Quick Ratio | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.4 | 1.2 | · | 1.8 | 2.2 | 2.3 | · | 2.8 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | -93.4 | -107.3 | -78.8 | · | -12.5 | -14.0 | -23.8 | · | -34.1 | -35.4 | -45.2 | · | -51.1 |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.1 | 1.9 | · | 2.0 | 1.7 | 1.7 | · | 1.6 | 1.4 | 1.4 | · | 1.1 | 1.1 | 1.2 | · | 1.2 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.68 | $12.43 | · | $9.10 | $9.11 | $9.12 | · | $7.08 | $6.78 | $6.50 | · | $6.59 | $5.23 | $5.74 | · | $3.72 | |
| Revenue / Share | $5.25 | $4.92 | · | $4.32 | $4.01 | $3.72 | · | $3.55 | $3.36 | $3.04 | · | $2.33 | $2.30 | $2.16 | · | $2.17 | |
| Cash Flow / Share | · | $0.28 | · | · | · | $0.33 | · | · | · | $0.22 | · | · | · | $-0.72 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.59 | |
| EPS (TTM) | $-1.35 | $-1.62 | · | $-2.29 | $-1.91 | $-1.47 | · | $-1.75 | $-2.44 | $-3.11 | · | $-4.52 | $-4.82 | $-5.35 | · | $-5.72 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.71B | $2.50B | · | $2.12B | $1.96B | $1.83B | · | $1.53B | $1.36B | $1.21B | · | $989M | $931M | $868M | · | $776M | |
| Net Income TTM | $-192M | $-226M | · | $-309M | $-253M | $-190M | · | $-215M | $-292M | $-365M | · | $-499M | $-512M | $-546M | · | $-546M | |
| Market Cap | $38.98B | $28.55B | · | $22.14B | $23.10B | $19.22B | · | $15.76B | $13.36B | $11.18B | · | $5.27B | $5.55B | $6.29B | · | $4.26B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.79B | |
| P/E | -201.1 | -123.5 | · | -70.3 | -88.5 | -96.2 | · | -72.5 | -44.4 | -29.4 | · | -9.8 | -10.1 | -10.4 | · | -7.7 | |
| P/S | 14.4 | 11.4 | · | 10.5 | 11.8 | 10.5 | · | 10.3 | 9.8 | 9.3 | · | 5.3 | 6.0 | 7.3 | · | 5.5 | |
| P/B | 21.4 | 16.1 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Tangible Book | 29.5 | 22.6 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Cash Flow | · | 710.6 | · | · | · | 432.4 | · | · | · | 414.0 | · | · | · | -77.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 4.9 | |
| Earnings Yield | -0.50% | -0.81% | · | -1.4% | -1.1% | -1.0% | · | -1.4% | -2.2% | -3.4% | · | -10.2% | -9.9% | -9.6% | · | -13.1% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $2.31B | $1.70B | $1.08B | $820M | $625M |
| Marge d'exploitation % | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% |
| Résultat net | $-208M | $-190M | $-435M | $-548M | $-472M |
| BPA dilué | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Ratio de liquidité | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 |
| Ratio de liquidité réduite | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $109M | $69M | $-286M | $-479M | $-376M |
Détenteurs institutionnels (13F) 928 déclarants · $36.5B total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
928
Valeur détenue
$36.5B
Nouvelles positions
166
Positions clôturées
63
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 166 (+55 vs T. préc.) | 63 (-37 vs T. préc.) | 359 (+56 vs T. préc.) | 247 (-14 vs T. préc.) | +8.7M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | $3 505 094 525 | 12 865 346 | 9,61% | Actions |
| BlackRock, Inc. | $2 962 770 331 | 10 914 608 | 8,12% | Actions |
| VANGUARD GROUP INC | $2 819 278 675 | 12 306 424 | 7,73% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 690 649 234 | 6 228 216 | 4,63% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 569 697 628 | 5 782 640 | 4,30% | Actions |
| FMR LLC | $1 479 781 281 | 5 451 396 | 4,06% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $1 096 858 330 | 4 040 738 | 3,01% | Actions |
| STATE STREET CORP | $992 317 506 | 3 655 618 | 2,72% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $744 565 293 | 2 750 013 | 2,04% | Actions |
| FRANKLIN RESOURCES INC | $739 946 472 | 2 725 903 | 2,03% | Actions |
| Castle Hook Partners LP | $704 759 120 | 2 596 276 | 1,93% | Actions |
| COATUE MANAGEMENT LLC | $680 006 681 | 2 505 090 | 1,86% | Actions |
| AQR CAPITAL MANAGEMENT LLC | $628 086 698 | 2 344 570 | 1,72% | Actions |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $602 175 451 | 2 218 366 | 1,65% | Actions |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $535 084 922 | 1 971 391 | 1,47% | Actions |
| NORGES BANK | $496 243 717 | 1 828 122 | 1,36% | Actions |
| FRED ALGER MANAGEMENT, LLC | $482 640 543 | 1 778 009 | 1,32% | Actions |
| GOLDMAN SACHS GROUP INC | $466 935 338 | 1 720 152 | 1,28% | Actions |
| Sofinnova Investments, Inc. | $420 823 506 | 1 550 280 | 1,15% | Actions |
| Capital World Investors | $408 365 851 | 1 504 387 | 1,12% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $408 180 994 | 1 503 706 | 1,12% | Actions |
| MAVERICK CAPITAL LTD | $368 266 171 | 1 356 663 | 1,01% | Actions |
| D. E. Shaw & Co., Inc. | $347 253 770 | 1 279 255 | 0,95% | Actions |
| MORGAN STANLEY | $345 906 057 | 1 274 287 | 0,95% | Actions |
| FEDERATED HERMES, INC. | $309 172 863 | 1 138 968 | 0,85% | Actions |
| Clearbridge Investments, LLC | $276 424 438 | 1 018 325 | 0,76% | Actions |
| RTW INVESTMENTS, LP | $271 450 000 | 1 000 000 | 0,74% | Actions |
| JANE STREET GROUP, LLC | $251 630 350 | 926 986 | 0,69% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $249 356 413 | 918 609 | 0,68% | Actions |
| Invesco Ltd. | $237 065 949 | 873 332 | 0,65% | Actions |
| NORTHERN TRUST CORP | $227 070 096 | 836 508 | 0,62% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $218 934 197 | 806 536 | 0,60% | Actions |
| BANK OF AMERICA CORP /DE/ | $199 960 146 | 736 637 | 0,55% | Actions |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $197 243 187 | 726 628 | 0,54% | Actions |
| ARK Investment Management LLC | $186 989 592 | 688 855 | 0,51% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $174 716 892 | 643 643 | 0,48% | Actions |
| Chevy Chase Trust Holdings, LLC | $162 830 912 | 599 856 | 0,45% | Actions |
| RAYMOND JAMES FINANCIAL INC | $160 992 382 | 593 083 | 0,44% | Actions |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $160 551 817 | 591 460 | 0,44% | Actions |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $150 579 670 | 752 936 | 0,41% | Actions |
| UBS Group AG | $150 312 452 | 553 739 | 0,41% | Actions |
| Legal & General Group Plc | $150 142 799 | 553 114 | 0,41% | Actions |
| Bank of New York Mellon Corp | $149 277 609 | 549 927 | 0,41% | Actions |
| FIRST TRUST ADVISORS LP | $138 768 953 | 511 214 | 0,38% | Actions |
| WELLS FARGO & COMPANY/MN | $136 489 991 | 502 818 | 0,37% | Actions |
| Nuveen, LLC | $135 477 536 | 499 089 | 0,37% | Actions |
| GILDER GAGNON HOWE & CO LLC | $135 199 396 | 498 064 | 0,37% | Actions |
| AMERICAN CENTURY COMPANIES INC | $129 951 802 | 478 732 | 0,36% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $125 949 543 | 463 988 | 0,35% | Actions |
| Avala Global LP | $124 867 000 | 460 000 | 0,34% | Actions |
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C., Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C., Dr. Michael F. Powell (“Powell”), Dr. James I. Healy ×3 dépôts | 13 février 2020 | · | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 21 initiés · 7 dirigeants · 15 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Steven Leonard Chapman | CEO AND PRESIDENT | 1 octobre 2026 S | 96 926 | 0 | 54 | $-90 749 334 |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 4 août 2026 S | 51 637 | 0 | 41 | $-21 731 496 |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1 octobre 2026 S | 106 914 | 0 | 64 | $-23 640 470 |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 10 août 2026 S | 197 257 | 0 | 18 | $-9 345 666 |
| Robert Alan Schueren | CHIEF OPERATING OFFICER | 27 janvier 2023 A | 24 091 | 0 | 0 | $0 |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 15 septembre 2026 S | 0 | 0 | 92 | $-124 045 289 |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 3 août 2026 S | 170 073 | 0 | 41 | $-23 609 158 |
| Jonathan Sheena | Administrateur | 23 septembre 2026 S | 9 000 | 0 | 144 | $-29 839 868 |
| Rowan E Chapman | Administrateur | 15 juillet 2026 S | 4 663 | 0 | 5 | $-1 764 386 |
| Eric H Rubin | Administrateur | 26 juin 2026 A | 2 204 | 0 | 0 | $0 |
| Monica Bertagnolli | Administrateur | 26 juin 2026 A | 7 020 | 0 | 0 | $0 |
| Gail Boxer Marcus | Administrateur | 26 juin 2026 A | 7 852 | 0 | 5 | $-2 413 550 |
| Roy D. Baynes | Administrateur | 26 juin 2026 A | 20 158 | 0 | 8 | $-2 809 687 |
| Thomas J. Lynch Jr. | Administrateur | 26 juin 2026 A | 1 905 | 0 | 0 | $0 |
| Herm Rosenman | Administrateur | 26 juin 2026 A | 5 927 | 0 | 5 | $-15 143 996 |
| ROELOF BOTHA ("RB") | Administrateur | 26 juin 2026 A | 4 585 | 0 | 17 | $-34 892 929 |
| Dr. James I. Healy | Administrateur | 25 avril 2025 A | 46 260 | 0 | 0 | $0 |
| Todd C Cozzens | Administrateur | 25 mai 2022 M | 15 813 | 0 | 0 | $0 |
| John Steuart | Administrateur | 16 mai 2019 M | 7 278 | 0 | 0 | $0 |
| Edward C. Driscoll Jr. | Administrateur | 16 mai 2019 M | 52 009 | 0 | 0 | $0 |
| Ruth Williams Brinkley | · | 24 avril 2026 A | 5 475 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 73 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 6,23% | 63 892 SH | 1 octobre 2026 | Quotidien |
| ARKG · ARK ETF Trust | 4,13% | 240 145 NS | 31 juillet 2026 | N-PORT |
| IBB · iShares Trust | 3,30% | 1 043 662 SH | 11 septembre 2026 | Quotidien |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 3,01% | 85 121 SH | 1 octobre 2026 | Quotidien |
| MEDI · Harbor ETF Trust | 2,26% | 3 475 NS | 31 juillet 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,23% | 87 424 NS | 31 juillet 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,23% | 5 764 NS | 31 juillet 2026 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 1,74% | 13 080 NS | 31 juillet 2026 | N-PORT |
| GURU · Global X Funds | 1,52% | 3 466 NS | 31 juillet 2026 | N-PORT |
| IWP · iShares Trust | 1,31% | 769 818 SH | 11 septembre 2026 | Quotidien |
| ARKK · ARK ETF Trust | 1,24% | 257 162 NS | 31 juillet 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 1,01% | 1 802 288 SH | 19 août 2026 | Quotidien |
| HQGO · Lattice Strategies Trust | 0,86% | 1 588 NS | 31 juillet 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,84% | 15 588 NS | 31 juillet 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,80% | 460 NS | 31 juillet 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,79% | 59 919 NS | 31 juillet 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,77% | 37 874 NS | 31 juillet 2026 | N-PORT |
| TEXN · iShares Trust | 0,74% | 426 SH | 11 septembre 2026 | Quotidien |
| IYH · iShares Trust | 0,72% | 79 898 SH | 11 septembre 2026 | Quotidien |
| IMCG · iShares Trust | 0,62% | 75 541 SH | 11 septembre 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,54% | 404 713 SH | 19 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,52% | 64 051 NS | 31 juillet 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,44% | 1 643 356 SH | 19 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,44% | 3 120 454 SH | 19 août 2026 | Quotidien |
| LQAI · Exchange Listed Funds Trust | 0,41% | 34 NS | 31 juillet 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,38% | 8 233 NS | 31 juillet 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,36% | 20 763 NS | 31 juillet 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,35% | 9 234 NS | 31 juillet 2026 | N-PORT |
| IWR · iShares Trust | 0,33% | 559 634 SH | 11 septembre 2026 | Quotidien |
| SIZE · iShares Trust | 0,32% | 4 182 SH | 11 septembre 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,32% | 20 796 SH | 1 octobre 2026 | Quotidien |
| IMCB · iShares Trust | 0,31% | 15 983 SH | 11 septembre 2026 | Quotidien |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 27 638 NS | 31 juillet 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,24% | 213 NS | 31 juillet 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,20% | 12 005 SH | 11 septembre 2026 | Quotidien |
| ILCG · iShares Trust | 0,14% | 13 232 SH | 11 septembre 2026 | Quotidien |
| IWF · iShares Trust | 0,14% | 513 245 SH | 11 septembre 2026 | Quotidien |
| VEGN · ETF Series Solutions | 0,12% | 801 NS | 31 juillet 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,12% | 2 314 SH | 1 octobre 2026 | Quotidien |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 132 NS | 31 juillet 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 216 186 SH | 19 août 2026 | Quotidien |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 7 532 SH | 19 août 2026 | Quotidien |
| HAPI · Harbor ETF Trust | 0,10% | 1 778 NS | 31 juillet 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,09% | 23 494 SH | 1 octobre 2026 | Quotidien |
| USCL · iShares Trust | 0,08% | 7 220 SH | 11 septembre 2026 | Quotidien |
| GARP · iShares Trust | 0,07% | 7 023 SH | 11 septembre 2026 | Quotidien |
| ILCB · iShares Trust | 0,07% | 2 633 SH | 11 septembre 2026 | Quotidien |
| IYY · iShares Trust | 0,07% | 6 130 SH | 11 septembre 2026 | Quotidien |
| ITOT · iShares Trust | 0,06% | 187 328 SH | 11 septembre 2026 | Quotidien |
| IWB · iShares Trust | 0,06% | 95 076 SH | 11 septembre 2026 | Quotidien |
| IWV · iShares Trust | 0,06% | 37 512 SH | 11 septembre 2026 | Quotidien |
| ESGV · VANGUARD WORLD FUND | 0,06% | 30 869 SH | 19 août 2026 | Quotidien |
| BKLC · BNY Mellon ETF Trust | 0,06% | 11 523 NS | 31 juillet 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,06% | 2 309 NS | 31 juillet 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,05% | 42 084 NS | 31 juillet 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,05% | 11 689 NS | 31 juillet 2026 | N-PORT |
| TOK · iShares Trust | 0,05% | 379 SH | 11 septembre 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,05% | 4 321 128 SH | 19 août 2026 | Quotidien |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,05% | 22 505 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,05% | 11 503 SH | 19 août 2026 | Quotidien |
| TOV · EA Series Trust | 0,05% | 479 NS | 31 juillet 2026 | N-PORT |
| URTH · iShares, Inc. | 0,05% | 11 995 SH | 11 septembre 2026 | Quotidien |
| CRBN · iShares Trust | 0,05% | 1 666 SH | 11 septembre 2026 | Quotidien |
| ACWI · iShares Trust | 0,04% | 42 227 SH | 11 septembre 2026 | Quotidien |
| TILT · FlexShares Trust | 0,04% | 3 402 NS | 31 juillet 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 3 537 NS | 31 juillet 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,04% | 18 510 NS | 31 juillet 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 113 866 SH | 19 août 2026 | Quotidien |
| DCOR · Dimensional ETF Trust | 0,03% | 3 396 NS | 31 juillet 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 42 957 NS | 31 juillet 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,02% | 132 NS | 31 juillet 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1 514 SH | 1 octobre 2026 | Quotidien |
| SMLF · iShares Trust | · | 96 755 SH | 11 septembre 2026 | Quotidien |
NTRA Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 30 analystes
ACHAT
Objectif médian
$360.00
-12,3%
12 40,0%
Achat fort
14 46,7%
Achat
4 13,3%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
23 analystes · 2026-09-28Objectif moyen $352.80 -14,0%
Maintenant
Prix actuel $410.35
Bas$280.00
Moyenne$352.80
Haut$460.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | · |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | · |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | · |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | · |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | · |
| RVMD | · | · | · | · | · | · |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | · |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | · |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | · |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | · |
Dernières actualités Actualités récentes mentionnant cette entreprise
Natera Inc. (NTRA) : Choix d'action du milliardaire Tom Steyer avec un grand potentiel de hausse
Yahoo Finance · 4 mois, 4 semaines il y a
Stanley Druckenmiller a réalisé un pari majeur qui semble toujours attrayant aujourd'hui et a réduit 2 positions de premier plan
Yahoo Finance · 5 mois, 2 semaines il y a
Natera Inc. (NTRA) : Le potentiel de hausse attire le milliardaire Stan Druckenmiller
Yahoo Finance · 5 mois, 3 semaines il y a
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 7, 2026